PLKO.1-YAP shRNA2 Citations (1)

Originally described in: Interferon-gamma induces tumor resistance to anti-PD-1 immunotherapy by promoting YAP phase separation.
Yu M, Peng Z, Qin M, Liu Y, Wang J, Zhang C, Lin J, Dong T, Wang L, Li S, Yang Y, Xu S, Guo W, Zhang X, Shi M, Peng H, Luo X, Zhang H, Zhang L, Li Y, Yang XP, Sun S Mol Cell. 2021 Feb 13. pii: S1097-2765(21)00010-1. doi: 10.1016/j.molcel.2021.01.010. PubMed Journal

---

Articles Citing PLKO.1-YAP shRNA2

Articles
Pharmacological Dissection Identifies Retatrutide Overcomes the Therapeutic Barrier of Obese TNBC Treatments through Suppressing the Interplay between Glycosylation and Ubiquitylation of YAP. Cui X, Zhu Y, Zeng L, Zhang M, Uddin A, Gillespie TW, McCullough LE, Zhao S, Torres MA, Wan Y. Adv Sci (Weinh). 2025 Mar;12(11):e2407494. doi: 10.1002/advs.202407494. Epub 2025 Jan 27. PubMed

If you have published an article using this material, please email us at to have your article added to this page.